Gara Jalqabaatti › Saree Oljoo › North Carolina

Qorannoo klinikaalii Saree Oljoo North Carolina keessatti

Qorannoo 91 Saree Oljoo f North Carolina keessatti hirmaatuu jiru.

Magaalota North Carolina keessatti

Takkalaa qorannoo (Ingiliffa)

The Vanguard Study: Testing a New Way to Screen for Cancer

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Durham VA Medical Center, Durham

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06995898

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Comprehensive Cancer Center at Wake Forest University (CCCWFU), Winston-Salem

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT02422641

A Study of PHST001 in Advanced Solid Tumors

Duke Cancer Institute, Durham

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Duke University, Durham

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Duke Cancer Network, Durham
Cone Health Cancer Center, Greensboro

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05827081

Distance-Based Exercise to Preserve Function and Prevent Disability

Novant Health Cancer Institute - Kernersville, Kernersville
Novant Health Cancer Institute - Mount Airy, Mount Airy
Novant Health Forsyth Medical Center, Winston-Salem

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
fi 6 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Levine Cancer, Charlotte

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07102381

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

University of North Carolina, Chapel Hill

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo

Umuriin 18 hanga 45 · Dubartoota · Haaromfame 01-Onk-2026 · NCT05557877

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06369285

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07360314

Radiation Therapy and Thymus Function in Young Women With Breast Cancer

Duke Cancer Center, Durham

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 hanga 50 · Dubartoota · Haaromfame 29-Ful-2026 · NCT07725172

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Duke Cancer Center, Durham

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06120283

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

University of North Carolina, Chapel Hill

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin hundi · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05440929

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Novant Health Cancer Institute ( Site 0019), Charlotte
Novant Health Oncology Specialists ( Site 0074), Winston-Salem

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Levine Cancer Institute ( Site 0014), Charlotte

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06312176

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Levine Cancer Institute, Albemarle
Levine Cancer Institute, Charlotte
Levine Cancer Institute, Charlotte
fi 11 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 60 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06377852

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Duke Cancer Institute, Durham

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07007559

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Carolinas Medical Center/Levine Cancer Institute, Charlotte

Namoota walitti qabaa jira

Umuriin 30 fi ol · Dubartoota · Haaromfame 25-Ful-2026 · NCT02945579

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Atrium Levine Cancer Institute, Charlotte

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Charlotte
Clinical Trial Site, Durham

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07085767

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Duke University Medical Center, Durham

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Messino Cancer Centers, Asheville
WakeMed Cancer Care - Waverly Hematology & Medical Oncology, Cary
University of North Carolina Medical Center, Chapel Hill
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

University of North Carolina Medical Center, Chapel Hill

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Dubartoota · Haaromfame 22-Ful-2026 · NCT07287098

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Atrium Health, Charlotte

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05894239

Identifying Patterns in the Breath of Individuals With Breast Cancer

Duke University Medical Cente, Durham

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 40 hanga 74 · Dubartoota · Haaromfame 18-Ful-2026 · NCT06512350

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07340541

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Oncology Specialists of Charlotte Pa, Charlotte
Carolina Oncology Specialists, Charlotte

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07173751

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07685938

Utility of a Mobile Application for Young Women With Breast Cancer

Atrium Health Levine Cancer, Charlotte

Namoota walitti qabaa jira

Umuriin 18 hanga 45 · Dubartoota · Haaromfame 15-Ful-2026 · NCT07009093

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Duke Cancer Institute, Durham
Cape Fear Valley Medical Center, Fayetteville
Cone Health Cancer Center at Wesley Long, Greensboro

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06492616

Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study

University of North Carolina at Chapel Hill, Chapel Hill

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 20 hanga 74 · Dubartoota · Haaromfame 14-Ful-2026 · NCT07214610

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Charlotte

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05123482

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Duke Cancer Institute, Durham

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT03424005

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Duke Cancer Institute, Durham

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06253871

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Levine Cancer Institute, Charlotte
Novant Health Cancer Institute, Charlotte
Novant Health Oncology Specialists, Winston-Salem

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07100106

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Duke Cancer Institute, Durham

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT05315700

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Novant Health Cancer Institute, Charlotte
Duke Cancer Institute, Durham
Novant Health Cancer Institute, Winston-Salem

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06790693

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

Duke University, Durham

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT05846789

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

University of North Carolina, Chapel Hill

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 50 fi ol · Dubartoota · Haaromfame 03-Ful-2026 · NCT06902311

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.